Mesenchymal Stem Cells to Treat Type 2 Diabetes

Clinical trial NCT02302599 · COMPLETED

Trial details

NCT number: NCT02302599
Sponsor: Chinese PLA General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mesenchymal Stem Cells

Start date: 2013-01-01
Primary completion: 2020-12-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.